thyroid surgery
Recently Published Documents


TOTAL DOCUMENTS

2323
(FIVE YEARS 605)

H-INDEX

63
(FIVE YEARS 7)

2022 ◽  
Author(s):  
Joaquin de Carlos ◽  
Ander Ernaga ◽  
Ana Irigaray ◽  
Jose Javier Pineda ◽  
Ana Echegoyen ◽  
...  

Abstract IntroductionIncidence of thyroid carcinoma (TC) has grown significantly over the last few decades worldwide, partly due to the increase detection of small thyroid microcarcinoma (TMc). TMc are tumors with a maximal diameter ≤ 1 cm, identified during histopathology examination following a thyroidectomy performed for reasons not pertaining to malignancy. The aim of this study is to investigate the prevalence of papillary thyroid microcarcinoma (PTMc) according to the nature of benign pathology that submit patients to thyroid surgery and its trend evolution.MethodsRetrospective cohort analysis of 1815 patients who underwent total thyroidectomy for non-malignant disease from 2005 to 2020. ResultsThe mean age of subjects was 53.5 years, with a higher proportion of women (1481, 82.1%). A total of 167 PTMc (9.3%) were incidentally discovered. Multivariate logistic regression analysis shows no differences in prevalence according to sex or age in patients with PTMc compared to those with final benign histology. Multinodular goiter increases the risk of PTMc with an odds ratio of 2.2 (p=0.001) compared to Hashimoto's thyroiditis and Graves´ disease (GD). There is a statistically significant increase in the incidence of PTMc in the group operated between 2017-2020 vs. 2005-2008 (p=0.005)ConclusionOverall prevalence of PTMc in patients who underwent thyroid surgery for benign disease was 9.3%. Thyroid nodular hyperplasia was the most frequent benign pathology associated to this occult cancer as compared to Hashimoto or GD. Gender and age were not correlated with prevalence of TMc. Over the years, surgical findings of PTMc have grown, particularly in the 2017-2020 period.


2022 ◽  
Vol 20 (1) ◽  
Author(s):  
Rong Cong ◽  
Xinying Li ◽  
Hui Ouyang ◽  
Wenbo Xue ◽  
Zeyu Zhang ◽  
...  

Abstract Background The safety of gasless endoscopic trans-axillary thyroid surgery is still undetermined. Methods Clinical findings and postoperative complications of patients who had undergone trans-axillary thyroid surgery due to thyroid cancer and thyroid nodules were retrospectively studied. The sensory change and paralysis results from this technique and patients’ satisfaction with the cosmesis were also studied. Results Fifty-one patients (49 females and 2 males) received operations by gasless, endoscopic trans-axillary approaches with one patient whose operation was converted to open surgery because of internal jugular vein injury. Only two patients developed temporary vocal cord paralysis and no patients developed other severe complications. The alleviation of the discomfort in the anterior neck area and sternocleidomastoid, and the cosmetic effect of gasless endoscopic trans-axillary thyroid surgery were acceptable. No evidence of recurrence was found during the follow-up period. Conclusions Gasless, endoscopic trans-axillary thyroid surgery is a feasible procedure with acceptable safety and better cosmetic results in strictly selected patients.


Author(s):  
Nicholas R. Scott-Wittenborn ◽  
Areej Shihabi ◽  
Jonathon O. Russell ◽  
Emad Kandil ◽  
Ralph Tufano

Author(s):  
Giuseppe Mercante ◽  
Andrea Costantino ◽  
Francesca Gaino
Keyword(s):  

Folia Medica ◽  
2021 ◽  
Vol 63 (6) ◽  
pp. 834-838
Author(s):  
Antoaneta Argatska ◽  
Boyan Nonchev

Thyroid surgery is generally recommended for malignant conditions and for some benign thyroid disorders. Many patients report weight gain after thyroidectomy especially during the first months following surgery. Studies on patients with Graves’ disease treated either with antithyroid drugs or radioiodine confirm that these patients frequently gain weight after restoration of thyroid function. Other studies have also shown that there is considerable weight gain after thyroidectomy for both nodular goiter and thyroid cancer. Transient hypothyroidism during the postoperative period is often thought to be associated with weight gain after thyroidectomy. The role of a number of adipocytokines and their interaction with the thyroid function has been investigated in the pathogenesis of weight changes. Levothyroxine replacement or suppressive therapy after thyroidectomy has a different impact on the metabolic parameters independent of TSH levels. The long-term effects of the impaired T3/T4 ratio are not fully understood as there are no sensitive markers to assess the biological response of target organs and tissues. Future studies are needed to identify such parameters, provide new considerations for the treatment of patients after total thyroidectomy, and help determine individual target hormone levels to ensure a sustained euthyroid state.


In Vivo ◽  
2021 ◽  
Vol 36 (1) ◽  
pp. 161-169
Author(s):  
BO HAE KIM ◽  
HEE-BOK KIM ◽  
JOO HYUN PARK ◽  
CHANG GUN CHO ◽  
SEOK-WON PARK ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document